Cellact Ltd., headquartered in Israel, is a pioneering company in the biotechnology sector, specialising in innovative cell-based therapies. Founded in 2015, Cellact has rapidly established itself as a leader in regenerative medicine, focusing on the development of advanced treatments for various medical conditions. The company’s core offerings include proprietary cell culture technologies and therapeutic solutions that stand out for their efficacy and safety. With a commitment to research and development, Cellact has achieved significant milestones, including collaborations with leading research institutions and successful clinical trials. Recognised for its contributions to the field, Cellact Ltd. continues to expand its operational reach, aiming to transform patient care through cutting-edge biotechnological advancements.
How does Cellact Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Telecommunications Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cellact Ltd.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cellact Ltd., headquartered in IL, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Cellact Ltd. may still be in the early stages of developing its climate commitments or reporting practices. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate accountability. Without specific emissions figures or reduction initiatives, it is unclear how Cellact Ltd. aligns with industry standards for carbon management or its potential impact on climate change. In the context of the broader industry, many companies are increasingly adopting Science-Based Targets (SBTi) and committing to net-zero emissions. It remains to be seen how Cellact Ltd. will approach its climate strategy moving forward.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cellact Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.